InVivoSIM anti-human PD-L1 (Atezolizumab Biosimilar)
SIM0009
ApplicationsFlow Cytometry, Western Blot, Neutralisation/Blocking
Product group Antibodies
ReactivityHuman
Overview
- SupplierBio X Cell
- Product NameInVivoSIM anti-human PD-L1 (Atezolizumab Biosimilar)
- Delivery Days Customer7
- ApplicationsFlow Cytometry, Western Blot, Neutralisation/Blocking
- CertificationResearch Use Only
- ClonalityMonoclonal
- Clone IDAtezolizumab
- Concentration4-11 mg/ml
- Estimated Purity≥95% , Determined by SDS-PAGE
- HostHuman
- IsotypeIgG1
- ReactivityHuman
- Storage Instruction2°C to 8°C
- UNSPSC41116161
References
- A CRISPR activation screen identifies MUC-21 as critical for resistance to NK and T cell-mediated cytotoxicity.Read this paper
- ROTACs leverage signaling-incompetent R-spondin for targeted protein degradation.Read this paper
- cis-B7:CD28 interactions at invaginated synaptic membranes provide CD28 co-stimulation and promote CD8(+) T cell function and anti-tumor immunity.Read this paper
Datasheet
Related products
Product group Antibodies
References
ApplicationsFlow Cytometry, Neutralisation/Blocking
ReactivityHuman, Mouse, Rat
- SizePrice
Product group Antibodies
- SizePrice
Product group Antibodies
ApplicationsFunctional Assay, ELISA, Neutralisation/Blocking
ReactivityHuman
- SizePrice
Product group Antibodies
ApplicationsFunctional Assay, Flow Cytometry, Western Blot, ELISA
ReactivityHuman
- SizePrice